4-hydroxyandrostenedione: A new treatment for postmenopausal patients with breast cancer

This publication has 7 references indexed in Scilit:

• An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients
  European Journal Of Cancer, 1992
• Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study)
  British Journal of Cancer, 1991
• Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer
  Cancer Chemotherapy and Pharmacology, 1991
• The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer
  British Journal of Cancer, 1990
• 4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER
  The Lancet, 1984
• Aminoglutethimide for the treatment of advanced postmenopausal breast cancer
  European Journal of Cancer and Clinical Oncology, 1983
• Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland
  Cancer, 1977